Clinical Trial Update: A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV [Phase 4]

View source ↗

Summary

This Phase 4 trial from the University of British Columbia is evaluating reduced dosing of the nonavalent HPV vaccine in women living with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: University of British Columbia | Conditions: HPV, Human Papilloma Virus | Phase 4 | Status: RECRUITING